{"id":656528,"date":"2025-03-10T06:05:10","date_gmt":"2025-03-10T03:05:10","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/colossal-ceo-ben-lamm-says-humanity-has-a-moral-obligation-to-pursue-de-extinction-tech\/"},"modified":"2025-03-10T06:05:10","modified_gmt":"2025-03-10T03:05:10","slug":"colossal-ceo-ben-lamm-says-humanity-has-a-moral-obligation-to-pursue-de-extinction-tech","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/colossal-ceo-ben-lamm-says-humanity-has-a-moral-obligation-to-pursue-de-extinction-tech\/","title":{"rendered":"#Colossal CEO Ben Lamm says humanity has a ‘moral obligation’ to pursue de-extinction tech"},"content":{"rendered":"
\n

The CEO of Colossal, a startup that aims to use genetic editing techniques to bring back extinct species, including the wooly mammoth, assured audiences at SXSW that the company has no plans to create a real-life Jurassic Park \u2014 lest there was any doubt. <\/p>\n

\u201cModern conservation isn\u2019t working [\u2026] and we\u2019re gonna need a \u2018de-extinction\u2019 toolkit,\u201d Colossal CEO Ben Lamm said during an onstage interview Sunday in Austin, responding to questions from actor and board member Joe Manga<\/a>niello. \u201cI think that we have a moral obligation and an ethical obligation to pursue technologies [that] undo some of the things that we [as a species] have done.\u201d<\/p>\n

Colossal is working to bring back the dodo bird and thylacine, commonly known as the Tasmanian tiger, well as the wooly mammoth, Lamm added. But the de-extinction of dinosaurs wouldn\u2019t be possible due to the lack of usable sources of dinosaur DNA. <\/p>\n

Dallas-based Colossal, founded in 2023 by Lamm and George Church, has stated that it wants to have woolly mammoth hybrid calves by 2028, which it hopes to reintroduce to the Arctic tundra habitat. The company is also leading a research project to release Tasmanian tiger joeys back to their original Tasmanian and broader Australian habitat after a period of captivity.<\/p>\n

That vision has resonated with investors. Colossal has raised hundreds of millions of dollars in venture capital, and it\u2019s currently valued at $10.2 billion.<\/p>\n

Colossal has spun out two companies focused on specific app<\/a>lications, including a third that hasn\u2019t yet been announced. Lamm also said he thinks there\u2019s \u201cbillions of dollars\u201d to be made from the \u201cre-wilding\u201d of species and carbon sequestration.<\/p>\n

One of Colossal\u2019s recent high-profile projects is the gene-edited \u201cwoolly mouse,\u201d a mouse species with mutations inspired by woolly mammoths. The mice, which exhibit long, shaggy, tawny-toned fur, were developed using a mix of mammoth-like and known mouse hair-growth mutations.<\/p>\n

Some experts have expressed skepticism of the new species, arguing that the experiment was more about mouse genetics than a breakthrough in de-extinction. <\/p>\n

Lamm, however, said the project validated Colossal\u2019s work on wooly mammoth research.<\/p>\n

\u201cIt showed us that, initially, our edits that we were making for the mammoth are the right edits,\u201d Lamm said. <\/p>\n

\"Colossal
Colossal Bioscience<\/a>s \u2013 woolly mouse<\/span>Image Credits:<\/strong>Colossal Biosciences<\/span><\/figcaption><\/figure>\n

Lamm touched on AI during the interview, saying that he believes that the combination of access to computing, AI, and synthetic biology will be the most \u201cdangerous\u201d set of technologies the world has seen. But he also painted an idealistic picture of the future, predicting that synthetic biology advances in particular will lead to cures for cancer, means of removing plastics from the oceans, and the widespread availability of clean water. <\/p>\n

\u201cWe will have true dominion over life, where we can eradicate species that are invasive or we can bring back lost species,\u201d Lamm said, \u201cand I think we\u2019ll also have the ability to engineer plants \u2014 not just for food consumption, but you will be able to engineer plants with different types of proteins.\u201d<\/p>\n

Lamm also said that he anticipates humanity will \u201cachieve longevity escape velocity\u201d in the next 20 years, adding years to the average human life expectancy and making immortality a theoretical possibility.<\/p>\n

Beyond human longevity, Lamm said de-extinction may require a \u201cManhattan Project-scale project\u201d to back up endangered species specifically in \u201cbio vaults\u201d to create stem and egg cells. Lamm said he\u2019s talked to \u201ca country that seems excited about it\u201d \u2014 without naming any names.<\/p>\n

On the subject of public sector work, Lamm mentioned that Colossal meets \u201cquarterly\u201d with U.S. government agencies and that the government has invested in Colossal, presumably via grants.<\/p>\n

\n<\/div>\n

If you liked the article, do not forget to share it with your friends. Follow us on\u00a0Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n

\n

If you want to read more like this article, you can visit our Technology<\/a><\/span> category.<\/strong><\/p>\n<\/blockquote>\n

Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

The CEO of Colossal, a startup that aims to use genetic editing techniques to bring back extinct species, including the wooly mammoth, assured audiences at SXSW that the company has no plans to create a real-life Jurassic Park \u2014 lest there was any doubt. \u201cModern conservation isn\u2019t working [\u2026] and we\u2019re gonna need a \u2018de-extinction\u2019…<\/p>\n","protected":false},"author":1,"featured_media":656529,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/techcrunch.com\/wp-content\/uploads\/2025\/03\/Screenshot-2025-03-09-at-2.28.04PM.png?resize=1200,654","fifu_image_alt":"","footnotes":""},"categories":[18],"tags":[151516,154806,70917,39230,154306,151454],"class_list":["post-656528","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-biotech-health","tag-colossal","tag-startups","tag-sxsw","tag-sxsw-2025","tag-tc"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/656528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=656528"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/656528\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/656529"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=656528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=656528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=656528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}